UNH
Income statement / Annual
Last year (2023), UnitedHealth Group Incorporated's total revenue was $371.62 B,
an increase of 15.36% from the previous year.
In 2023, UnitedHealth Group Incorporated's net income was $22.38 B.
See UnitedHealth Group Incorporated’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$371.62 B
|
$322.13 B
|
$285.27 B
|
$255.64 B
|
$242.16 B
|
$226.25 B
|
$201.16 B
|
$184.83 B
|
$157.11 B
|
$130.47 B
|
| Cost of Revenue |
$284.75 B |
$244.55 B |
$217.95 B |
$190.14 B |
$184.56 B |
$172.40 B |
$154.15 B |
$141.45 B |
$120.08 B |
$97.04 B |
| Gross Profit |
$86.87 B |
$77.59 B |
$67.33 B |
$65.50 B |
$57.60 B |
$53.85 B |
$47.01 B |
$43.37 B |
$37.03 B |
$33.43 B |
| Gross Profit Ratio |
0.23 |
0.24 |
0.24 |
0.26 |
0.24 |
0.24 |
0.23 |
0.23 |
0.24 |
0.26 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$54.63 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$284.64 B |
$3.40 B |
$3.10 B |
$2.89 B |
$2.72 B |
$2.43 B |
$2.25 B |
$1.69 B |
$1.69 B |
$1.90 B |
| Operating Expenses |
$339.26 B |
$51.18 B |
$45.68 B |
$44.60 B |
$37.91 B |
$36.50 B |
$31.80 B |
$30.09 B |
$26.01 B |
$23.16 B |
| Cost And Expenses |
$339.26 B |
$295.73 B |
$263.63 B |
$234.74 B |
$222.47 B |
$208.90 B |
$185.95 B |
$171.55 B |
$146.09 B |
$120.20 B |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$3.25 B |
$2.09 B |
$1.66 B |
$1.66 B |
$1.70 B |
$1.40 B |
$1.19 B |
$1.07 B |
$790.00 M |
$618.00 M |
| Depreciation &
Amortization |
$3.97 B
|
$3.40 B
|
$3.10 B
|
$2.89 B
|
$2.72 B
|
$2.43 B
|
$2.25 B
|
$2.06 B
|
$1.69 B
|
$1.48 B
|
| EBITDA |
$36.33 B
|
$31.84 B
|
$27.07 B
|
$25.30 B
|
$22.41 B
|
$19.77 B
|
$17.45 B
|
$14.99 B
|
$12.71 B
|
$11.75 B
|
| EBITDA Ratio |
0.1 |
0.09 |
0.09 |
0.09 |
0.09 |
0.09 |
0.09 |
0.08 |
0.08 |
0.09 |
| Operating Income Ratio
|
0.09
|
0.09
|
0.08
|
0.09
|
0.08
|
0.08
|
0.08
|
0.07
|
0.07
|
0.08
|
| Total Other
Income/Expenses Net |
-$3.25 B
|
-$2.09 B
|
-$1.66 B
|
-$1.66 B
|
-$1.70 B
|
-$1.40 B
|
-$1.19 B
|
-$1.07 B
|
-$790.00 M
|
-$618.00 M
|
| Income Before Tax |
$29.11 B |
$26.34 B |
$22.31 B |
$20.74 B |
$17.98 B |
$15.94 B |
$14.02 B |
$12.21 B |
$10.23 B |
$9.66 B |
| Income Before Tax Ratio
|
0.08
|
0.08
|
0.08
|
0.08
|
0.07
|
0.07
|
0.07
|
0.07
|
0.07
|
0.07
|
| Income Tax Expense |
$5.97 B |
$5.70 B |
$4.58 B |
$4.97 B |
$3.74 B |
$3.56 B |
$3.20 B |
$4.92 B |
$4.36 B |
$4.04 B |
| Net Income |
$22.38 B |
$20.12 B |
$17.29 B |
$15.40 B |
$13.84 B |
$11.99 B |
$10.56 B |
$7.24 B |
$5.81 B |
$5.62 B |
| Net Income Ratio |
0.06 |
0.06 |
0.06 |
0.06 |
0.06 |
0.05 |
0.05 |
0.04 |
0.04 |
0.04 |
| EPS |
24.12 |
21.54 |
18.33 |
16.28 |
14.55 |
12.45 |
10.95 |
7.37 |
6.1 |
5.78 |
| EPS Diluted |
23.86 |
21.18 |
18.08 |
16.03 |
14.33 |
12.19 |
10.72 |
7.25 |
6.01 |
5.7 |
| Weighted Average Shares
Out |
$928.00 M
|
$934.00 M
|
$943.00 M
|
$946.00 M
|
$951.00 M
|
$963.00 M
|
$964.00 M
|
$952.00 M
|
$953.00 M
|
$972.00 M
|
| Weighted Average Shares
Out Diluted |
$938.00 M
|
$950.00 M
|
$956.00 M
|
$961.00 M
|
$966.00 M
|
$983.00 M
|
$985.00 M
|
$968.00 M
|
$967.00 M
|
$986.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
